Millennium Management’s KALA BIO KALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,721
| Closed | -$944K | – | 6151 |
|
|
2024
Q4 | $944K | Sell |
2,721
-94
| -3% | -$29.6K | ﹤0.01% | 4248 |
|
|
2024
Q3 | $802K | Sell |
2,815
-31
| -1% | -$9.78K | ﹤0.01% | 4442 |
|
|
2024
Q2 | $1.01M | Buy |
2,846
+178
| +7% | +$58.8K | ﹤0.01% | 4103 |
|
|
2024
Q1 | $1.05M | Buy |
2,668
+15
| +0.6% | +$5.57K | ﹤0.01% | 4257 |
|
|
2023
Q4 | $929K | Sell |
2,653
-34
| -1% | -$12K | ﹤0.01% | 4220 |
|
|
2023
Q3 | $1.2M | Buy |
2,687
+110
| +4% | +$72.2K | ﹤0.01% | 4046 |
|
|
2023
Q2 | $1.88M | Sell |
2,577
-292
| -10% | -$227K | ﹤0.01% | 3535 |
|
|
2023
Q1 | $2.16M | Buy |
2,869
+1,355
| +89% | +$1.18M | ﹤0.01% | 3370 |
|
|
2022
Q4 | $2.89M | Buy |
1,514
+1,291
| +579% | +$511K | ﹤0.01% | 3247 |
|
|
2022
Q3 | $124K | Sell |
223
-6
| -3% | -$4.71K | ﹤0.01% | 5888 |
|
|
2022
Q2 | $172K | Buy |
229
+209
| +1,045% | +$328K | ﹤0.01% | 5709 |
|
|
2022
Q1 | $69K | Sell |
20
-5
| -20% | -$13.1K | ﹤0.01% | 6299 |
|
|
2021
Q4 | $76K | Sell |
25
-36
| -59% | -$167K | ﹤0.01% | 6361 |
|
|
2021
Q3 | $401K | Buy |
61
+50
| +455% | +$432K | ﹤0.01% | 5553 |
|
|
2021
Q2 | $150K | Sell |
11
-270
| -96% | -$4.24M | ﹤0.01% | 6118 |
|
|
2021
Q1 | $4.72M | Sell |
281
-50
| -15% | -$976K | ﹤0.01% | 2629 |
|
|
2020
Q4 | $5.61M | Buy |
331
+215
| +185% | +$4.05M | ﹤0.01% | 2331 |
|
|
2020
Q3 | $2.17K | Sell |
116
-27
| -19% | -$621K | ﹤0.01% | 2536 |
|
|
2020
Q2 | $3.75M | Sell |
143
-194
| -58% | -$5.5M | 0.01% | 2025 |
|
|
2020
Q1 | $7.4M | Buy |
337
+117
| +53% | +$1.87M | 0.02% | 1055 |
|
|
2019
Q4 | $2.02M | Sell |
220
-4
| -2% | -$38.6K | ﹤0.01% | 2615 |
|
|
2019
Q3 | $2.13M | Sell |
224
-4
| -2% | -$48.7K | ﹤0.01% | 2404 |
|
|
2019
Q2 | $3.63M | Sell |
228
-94
| -29% | -$1.56M | 0.01% | 2025 |
|
|
2019
Q1 | $6.66M | Buy |
322
+258
| +403% | +$4.58M | 0.01% | 1560 |
|
|
2018
Q4 | $787K | Sell |
64
-93
| -59% | -$1.61M | ﹤0.01% | 2710 |
|
|
2018
Q3 | $3.88M | Sell |
157
-83
| -35% | -$2.53M | ﹤0.01% | 1992 |
|
|
2018
Q2 | $8.22M | Sell |
240
-160
| -40% | -$6.14M | 0.01% | 1463 |
|
|
2018
Q1 | $15.8M | Buy |
400
+359
| +876% | +$13.6M | 0.02% | 1021 |
|
|
2017
Q4 | $1.91M | Buy |
41
+16
| +64% | +$749K | ﹤0.01% | 2313 |
|
|
2017
Q3 | $1.41M | Buy |
+25
| New | +$1.37M | ﹤0.01% | 2342 |
|
Other funds holding KALA
BBA
CAM
SOCM
ACM
PA
WP
SCM
ACM
UOC
Millennium Management's KALA Position: Q1 2025 in Review
Millennium Management sold out of KALA BIO (KALA) in Q1 2025, closing a stake of 2,721 shares — an estimated $944K sold.
Millennium Management first reported a position in KALA in Q3 2017 and held it in 30 quarters. The position peaked at $15.8M in Q1 2018. 25 funds tracked by Wall St. Rank hold KALA as of Q1 2025.
- Millennium Management reported no remaining KALA BIO position as of Q1 2025 after selling out during the quarter.
- Millennium Management sold 2,721 KALA BIO shares in Q1 2025, an estimated $944K.
- Millennium Management first reported a position in KALA BIO in Q3 2017 and held it in 30 quarters.
- Millennium Management's KALA BIO position peaked at $15.8M in Q1 2018.
- 25 funds tracked by Wall St. Rank held KALA BIO as of Q1 2025.
Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.